Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lund

Showing results (201-210 of 435) with videos related to

Pageof 44
Sort By:
Pharmacoepidemiology and Drug Safety|September 24, 2023
The association between wealth and sleep medication use in a nationally-representative sample of older Medicare beneficiariesAllison Musty, Jennifer L Lund, Yang Claire Yang, et al.
Journal of Geriatric Oncology|November 26, 2024
Potential drug-drug interactions between cancer therapies and active antiretroviral treatments among Medicare-enrolled patients with cancer and HIVJessica Y Islam, Xi Zhou, Christopher Baggett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with CyclophosphamideChristine D Hsu, Sharon Peacock Hinton, Katherine E Reeder-Hayes, et al.
Journal of Geriatric Oncology|June 12, 2017
Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancerCaroline Mariano, Jennifer L Lund, Sharon Peacock Hinton, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 20, 2019
Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapyDanielle S Chun, Aimee Faso, Hyman B Muss, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2020
Ondansetron use in early pregnancy and the risk of late pregnancy outcomesElizabeth A Suarez, Kim Boggess, Stephanie M Engel, et al.
Medical Care Research and Review : MCRR|August 3, 2010
Use of qualitative methods in published health services and management research: a 10-year reviewBryan J Weiner, Halle R Amick, Jennifer L Lund, et al.
Epidemiology (Cambridge, Mass.)|August 3, 2020
Reweighting Oranges to Apples: Transported RE-LY Trial Versus Nonexperimental Effect Estimates of Anticoagulation in Atrial FibrillationMichael Webster-Clark, Jennifer L Lund, Til Stürmer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 29, 2012
An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergyC Rask, L Lund, G Lund, et al.
Pharmacoepidemiology and Drug Safety|July 16, 2020
Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adultsMichael Webster-Clark, Til Stürmer, Jessie K Edwards, et al.
Pageof 44

Showing results (201-210 of 435) with videos related to

Sort By:
Pageof 44
Pharmacoepidemiology and Drug Safety|September 24, 2023
The association between wealth and sleep medication use in a nationally-representative sample of older Medicare beneficiariesAllison Musty, Jennifer L Lund, Yang Claire Yang, et al.
Journal of Geriatric Oncology|November 26, 2024
Potential drug-drug interactions between cancer therapies and active antiretroviral treatments among Medicare-enrolled patients with cancer and HIVJessica Y Islam, Xi Zhou, Christopher Baggett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with CyclophosphamideChristine D Hsu, Sharon Peacock Hinton, Katherine E Reeder-Hayes, et al.
Journal of Geriatric Oncology|June 12, 2017
Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancerCaroline Mariano, Jennifer L Lund, Sharon Peacock Hinton, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 20, 2019
Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapyDanielle S Chun, Aimee Faso, Hyman B Muss, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2020
Ondansetron use in early pregnancy and the risk of late pregnancy outcomesElizabeth A Suarez, Kim Boggess, Stephanie M Engel, et al.
Medical Care Research and Review : MCRR|August 3, 2010
Use of qualitative methods in published health services and management research: a 10-year reviewBryan J Weiner, Halle R Amick, Jennifer L Lund, et al.
Epidemiology (Cambridge, Mass.)|August 3, 2020
Reweighting Oranges to Apples: Transported RE-LY Trial Versus Nonexperimental Effect Estimates of Anticoagulation in Atrial FibrillationMichael Webster-Clark, Jennifer L Lund, Til Stürmer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 29, 2012
An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergyC Rask, L Lund, G Lund, et al.
Pharmacoepidemiology and Drug Safety|July 16, 2020
Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adultsMichael Webster-Clark, Til Stürmer, Jessie K Edwards, et al.
Pageof 44